Cargando…

PB2363: REPORTING LANGUAGE IN HAEMATOLOGICAL MALIGNANCIES

Detalles Bibliográficos
Autores principales:	Watt, S., Ralston, S., Evans-Tomlinson, A., Burthem, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429873/ http://dx.doi.org/10.1097/01.HS9.0000852276.38273.5b

Ejemplares similares

PB2363: R-MPV FOLLOWED BY CONSOLIDATION REDUCED-DOSE WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: REAL WORLD DATA
por: Amani, Maha EL, et al.
Publicado: (2023)

PB2000: A COMPREHENSIVE NGS PANEL APPROACH FOR CLINICAL GENOMIC ANALYSIS IN HAEMATOLOGICAL MALIGNANCY
por: Mason, Joanne, et al.
Publicado: (2023)

PB2459: AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES OF HAEMATOLOGIC MALIGNANCIES COMPLICATED BY AUTOIMMUNE DISEASES
por: Kang, Ying, et al.
Publicado: (2023)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
por: Kiesewetter, Barbara, et al.
Publicado: (2023)

PB1714: DEXRAZOXANE IN HAEMATOLOGICAL PATIENTS: A META-ANALYSIS OF THE CARDIOPROTECTIVE EFFICACY, RISK OF SECONDARY MALIGNANCIES AND IMPACT IN SURVIVAL OUTCOMES
por: Pimenta, Mario Sousa, et al.
Publicado: (2023)

PB2545: HAEMATOLOGICAL INDICES IN DIFFERENTIAL DIAGNOSIS OF MICROCYTIC ANEMIAS, A REGIONAL STUDY
por: Myrtaj, Rialda, et al.
Publicado: (2023)

PB2192: THE IMPACT OF DENTAL DISEASE ON THE MANAGEMENT OF HAEMATOLOGICAL DISEASE: A REVIEW OF TWO CASES
por: Miles, E., et al.
Publicado: (2022)

PB2563: IRON DEFICIENCY ANEMIA: A MONOCENTRIC EXPERIENCE OF THE HAEMATOLOGY DEPARTMENT OF MONASTIR, TUNISIA
por: Bouhoula, Donia, et al.
Publicado: (2023)

PB2085: EPIDEMIOLOGICAL DESCRIPTION AND PROGNOSIS FEATURES OF MULTIPLE MYELOMA IN A TUNISIAN HAEMATOLOGY CENTER
por: Boughanmi, Sarah, et al.
Publicado: (2023)

PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY
por: Hariharan, L., et al.
Publicado: (2022)

PB1809: COMPARISON OF OPTICAL GENOME MAPPING WITH STANDARD OF CARE TESTING TO INVESTIGATE GENOMIC ABNORMALITIES IN HAEMATOLOGICAL MALIGNANCIES: THE EXPERIENCE OF CENTRAL AND SOUTH GENOMIC LABORATORY HUB, UK
por: Muraru, Mariela, et al.
Publicado: (2023)

PB2348: THE PATIENT’S PERSPECTIVE ON CLNICAL TRIALS: RESULTS FROM A REGIONAL SURVEY IN HAEMATOLOGICAL CENTERS IN ANTWERP
por: Heyrman, B., et al.
Publicado: (2022)

PB2420: DEVELOPMENT AND VALIDATION OF THE PRACT MODEL FOR ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS ABOVE 60 YEARS OLD WITH HAEMATOLOGICAL MALIGNANCIES IN A REAL-WORLD STUDY
por: Liu, Jing, et al.
Publicado: (2023)

PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS
por: Vázquez, Celia Martinez, et al.
Publicado: (2023)

PB2120: HIV AND MALIGNANT HEMOPATHIES
por: Khibri, H., et al.
Publicado: (2022)

PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.
por: Minarik, L., et al.
Publicado: (2022)

PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY.
por: Dos Santos, G., et al.
Publicado: (2022)

PB2693: ANEMIA IN HEMATOLOGIC MALIGNANCIES: NOT ONLY A SYMPTOM.
por: Hari, Oumayma, et al.
Publicado: (2023)

PB1890: ZANUBRUTINIB IN ACALABRUTINIB-INTOLERANT PATIENTS (PTS) WITH B-CELL MALIGNANCIES
por: Shadman, M., et al.
Publicado: (2022)

PB2587: BLOODSTREAM INFECTIONS AMONG PATIENTS WITH HEMATOLOGICAL MALIGNANCY IN ARMENIA
por: Soghomonyan, Diana, et al.
Publicado: (2023)

PB1833: STREAMLINED WORKFLOW FOR ANALYZING AND REPORTING OPTICAL GENOME MAPPING FOR HEMATOLOGICAL MALIGNANCIES IN BIONANO VIA SOFTWARE
por: Hastie, Alex, et al.
Publicado: (2023)

PB2273: ANALYSIS OF THE HAEMATOLOGICAL PARAMETERS AND BLOOD PICTURE FINDINGS AND THEIR IMPACT ON THE DURATION OF STAY IN A COHORT OF PATIENTS WITH COVID 19 INFECTION IN A TERTIARY CARE HOSPITAL IN SRI LANKA
por: Kariyawasan, C., et al.
Publicado: (2022)

PB2358: SIGNIFICANT INCREASE IN NEWLY DIAGNOSED HEMATOLOGICAL MALIGNANCIES FOLLOWING LOCKDOWN EASE IN CROATIA
por: Simunic, M., et al.
Publicado: (2022)

PB2362: BEST PRACTICES ON EMPOWERING AND INVOLVING PATIENTS LIVING WITH HEMATOLOGICAL MALIGNANCIES ON THE DEVELOPMENT OF NOVEL PATIENT-REPORTED OUTCOME MEASURES
por: Vrontaras, N., et al.
Publicado: (2022)

PB2700: ANXIETY AND DEPRESSION IN HEMATOLOGICAL MALIGNANCIES PATIENTS: FOCUS ON TREATMENT ADHERENCE
por: Vybornykh, Dmitry E, et al.
Publicado: (2023)

PB1748: LOW HAIR CORTISOL CONCETRANTIONS AT DIAGNOSIS OF CHILDHOOHD HEMATOLOGICAL MALIGNANCIES
por: Kourou, Panagiota, et al.
Publicado: (2023)

PB1915: SOMATIC ALTERATIONS IN PATIENTS WITH INHERITED MYELOID MALIGNANCIES SYNDROMES: A SINGLE-CENTER STUDY
por: Santiago Balsera, M., et al.
Publicado: (2022)

PB2255: ANTIMICROBIAL SUSCEPTIBILITY TO MICROORGANISMS IN HEMATOLOGICAL MALIGNANCIES; A NEED TO REVIEW INSTITUTIONAL PROTOCOLS
por: ANWAR, N., et al.
Publicado: (2022)

PB2350: HEMATOLOGIC MALIGNANCIES AND AUTO-IMMUNITY: A CASE SERIES OF 21 PATIENTS
por: Hanani, Hind, et al.
Publicado: (2023)

PB2261: LINEZOLID AS A SAFE ANTIMICROBIAL AGENT IN THROMBOCYTOPENIC PATIENTS UNDERGOING CHEMOTHERAPY FOR HEMATOLOGIC MALIGNANCIES
por: Angotzi, F., et al.
Publicado: (2022)

PB2200: CLONAL HEMATOPOIESIS AT THE CROSSROADS OF INFLAMMATORY BOWEL DISEASES AND HEMATOLOGICAL MALIGNANCIES: A BIOLOGICAL LINK?
por: Cumbo, C., et al.
Publicado: (2022)

PB1719: NIRAPARIB IN B-CELL LYMPHOID MALIGNANCIES: EXPLORING SYNTHETIC LETHALITY AS TARGET FOR THERAPY
por: Lapa, Beatriz, et al.
Publicado: (2023)

PB2049: MEXICAN REGISTRY OF MYELOPROLIFERATIVE NEOPLASMS. INITIAL REPORT
por: De La Peña Celaya, J. A., et al.
Publicado: (2022)

PB2159: FREQUENCY OF PRACTICE-CHANGING FINDINGS IDENTIFIED BY COMPREHENSIVE GENOMIC PROFILING IN NON-MYELOID HEMATOLOGIC MALIGNANCIES
por: Lin, C., et al.
Publicado: (2022)

PB2704: PREDICTING HEMATOLOGICAL MALIGNANCIES USING COMPLETE BLOOD CELL COUNTS FROM PRIMARY CARE
por: Christensen, Mathilde, et al.
Publicado: (2023)

PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY
por: Buquicchio, Caterina, et al.
Publicado: (2023)

PB2246: FEATURES OF THE SECRETION OF HEPCIDIN, A SOLUBLE TRANSFERRIN RECEPTOR DEPENDING ON THE TYPE OF ANEMIA IN PATIENTS WITH MALIGNANT NEOPLASMS
por: Sakhin, V., et al.
Publicado: (2022)

PB2323: ACQUIRED HEMOPHILIA: A CASE REPORT
por: Haddad, N., et al.
Publicado: (2022)

PB2099: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-1607, A FIRST-IN-CLASS ORAL CBL-B INHIBITOR, IN PATIENTS WITH ADVANCED MALIGNANCIES INCLUDING RICHTER TRANSFORMATION DLBCL
por: Sharp, A., et al.
Publicado: (2022)

PB2699: CONSENSUS FROM AN EXPERT PANEL ON THE CURRENT MANAGEMENT OF SECONDARY IMMUNODEFICIENCY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN SPAIN
por: Boqué, Concepción, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gqfe6bigaul11lhm38vn5hm22p